International Vaccine Institute strategic demand forecasting; and Sabin – communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in Brazil, Burkina Faso, Cambodia, Colombia, Gabon, India, Kenya, Thailand, and Vietnam. From 2013-2015, with funding from Germany’s Federal Ministry of Education & Research (BMBF), IVI continued support for preclinical development of dengue vaccines by Brazil’s Butantan Institute and Vietnam’s VaBiotech. After the 2016 licensure of Sanofi Pasteur’s Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to
American Independent Institute [it covers] and the content of individual stories". In 2014, the dormant American Independent News Network organization was re-launched by David Brock as the American Independent Institute, a journalistic grant-making entity focused on liberal investigative journalism. "The Nation" reported that year that Brock's newly relaunched group would disperse $320,000 in grants to "reporters investigating right-wing misdeeds." American Independent Institute The American Independent Institute is a nonprofit organization which funds liberal investigative journalism efforts. According to the organization, its aim is to support journalism which exposes "the nexus of conservative power in Washington." The current institute, started by David Brock in